Recent Reports




Evidence report on cystic fibrosis. Due to the COVID-19 pandemic, the public meeting to discuss this report has been postponed to August 27, 2020. 

View More on this Topic


Materials

ICER

ICER Methods Adaptations for Pandemic-Related Value Assessments

ICER

Alternative Policies for Pricing Novel Vaccines and Drug Therapies for COVID-19

ICER

COVID-19: Updated Assessment

ICER

COVID-19: Preliminary Assessment

CTAF

Anemia in Chronic Kidney Disease: Stakeholder List

CTAF

Anemia in Chronic Kidney Disease: Draft Scoping Document

CTAF

Anemia in Chronic Kidney Disease: Open Input Period

ICER

2020 Unsupported Price Increase Report: Protocol

ICER

Methods adaptations for evaluating pricing during a pandemic

ICER

COVID-19: Public Comments on Preliminary Assessment

Midwest CEPAC

High Cholesterol Update: Revised Scoping Document

Midwest CEPAC

High Cholesterol Update: Stakeholder List